The Use of Blood-Based Biomarkers in the Evaluation and Management of Pulmonary Nodules Published 2020-05-26 Download video MP4 360p Download video MP4 720p Recommendations 1:01:57 Lung Cancer Biomarker Testing: Improving Turnaround from Presentation to Treatment 1:31:05 Implications of Shape-Sensing Robotic Bronchoscopy in a Lung Cancer Practice 01:18 5 mm Lung nodule biposy using robotic bronchoscopy with the fluoroscopy augmentation CBCT 12:15 INTERSTITIAL LUNG DISEASES- Radiopathology l HRCT chest l Approach to diagnosis l treatment l 58:09 What is Biomarker Testing for Advanced Lung Cancer and Why Is It Important? 56:35 Challenges and Opportunities for Defining Arrhythmogenic Substrates in Ventricular Arrhythmias 46:57 The Leading Edge: Efzofitimod, the MostAdvanced Sarcoidosis InvestigationalTreatment 50:25 Antibiotic Use in Suspected Sepsis: Navigating Between Conservative and Aggressive Approaches 1:01:47 Tissue is the Issue: Using EBUS to Acquire & Process Tissue for Biomarker Testing in Adv Lung Cancer 55:05 Enhancing NSCLC Biomarker Testing: Introducing a Practical Clinician Checklist 57:19 The Impact of an All-Nebulizer Management Strategy in the Acute Care Setting - Dec 12, 2023 2:19:51 Opening Session at CHEST 2023 Annual Meeting 1:37:34 CHEST Challenge at CHEST 2023 Annual Meeting 31:21 Antibiotic Use in Suspected Sepsis: Navigating Conservative and Aggressive Approaches - PART 1 12:41 The latest long COVID news, rising flu cases and funding for gun violence prevention research 19:11 Antibiotic Use in Suspected Sepsis: Navigating Conservative and Aggressive Approaches - PART 2 03:29 Grow, Connect, and Be Inspired at CHEST 2023 Annual Meeting 03:32 Matching the Patient with the Delivery Device: When is a Nebulizer the Best Choice? 01:03 CHEST 2023 Annual Meeting Recap 00:36 What clinicians can expect from CHEST® Pulmonary Similar videos 31:31 Evaluation and Management of Patients With Pulmonary Nodules 48:52 Using Biomarker-Based Risk Assessments to Inform Lung Nodule Referral Decisions 50:13 Pulmonary Nodules 32:54 Reclassifying malignancy risk in indeterminate pulmonary nodules using Nodify Lung™ testing strategy 1:44:29 Pulmonary Nodules: State of the Art Rapid Fire 28:50 Evaluating lung nodules during the COVID-19 pandemic using blood-based biomarkers 10:02 Demystifying Lung Nodules 29:02 Sampling and Evaluating Lung Nodules and Masses: Expert Q&A 59:32 Lung Nodules 1:01:35 WEBINAR REPLAY: Evolution of Clinical Evidence of the Blood-based Nodify Lung Nodule Risk Assessment 38:25 How to follow up solitary pulmonary nodule (Fleischner 2017 Guideline), 8 different scenarios. 39:48 How do we bring lung cancer diagnostic biomarkers to the clinic? 45:36 Evaluation of Thyroid Nodules 52:55 Using a Blood-Based Biomarker in Patients with Pulmonary Nodules in a Real-World Observational Study 36:00 Enhanced Performance of the Nodify XL2 Blood-Based Lung Nodule Test 1:22:23 The Changing Landscape of Pulmonary Nodule Management 1:11:07 NBE-APPROACH TO SOLITARY PULMONARY NODULE & SCREENING IN LUNG CANCER- DR. SARVANA & DR. PRASANTH 1:54:09 Incidental pulmonary nodule (IPN): A pandora's box. More results